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Abstract Utilizing Marathon-ready cDNA library and a gene-
specific primer corresponding to a partial amino acid sequence
determined previously, the complete nucleotide sequence for the
cDNA of crocalbin, which binds crotoxin (a phospholipase A2)
and Ca2+, was obtained by polymerase chain reaction. The open
reading frame of the cDNA encodes a novel polypeptide of 315
amino acid residues, including a signal sequence of 19 residues.
This protein contains six potential Ca2+-binding domains, one N-
glycosylation site, and a large amount of acidic amino acid
residues. The ability to bind Ca2+ has been ascertained by
calcium overlay experiment. Evidenced by sequence similarity in
addition, it is concluded that crocalbin is a new member of the
reticulocalbin family of calcium-binding proteins.
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1. Introduction
Synaptic transmission is vulnerable to a variety of neuro-
toxins. Among these toxins some exhibit phospholipase A2
(PLA2, EC 3.1.1.4) activity. These PLA2 neurotoxins (or neu-
rotoxic PLA2s) from di¡erent sources have been studied ex-
tensively in recent years, mostly in terms of structural, phar-
macological and electrophysiological aspects. Based on
structural and catalytic di¡erences, PLA2s have been classi¢ed
into several groups. Most of the proteins are monomeric and
most of the PLA2 chains from di¡erent sources are homolo-
gous in structural features. PLA2s play important roles in
phospholipid metabolism, host defense and signal transduc-
tion. Many of them also exhibit neurotoxicity, myotoxicity,
coagulation e¡ects and other biological actions, which may or
may not be related to hydrolysis of phospholipids. A small
number of the PLA2 proteins, including crotoxin from the
South American rattlesnake Crotalus durissus terri¢cus, a¡ect
primarily the presynaptic site to cause ultimate blockade of
synaptic transmission by inhibiting the release of neurotrans-
mitters, though most of them also show postsynaptic toxicity
and other e¡ects (see [1^12] for recent reviews). Previously we
have identi¢ed high-a⁄nity binding proteins for crotoxin by
photoa⁄nity labeling and chemical cross-linking techniques
[13^15]. Two polypeptides of V50 kDa and 18 kDa have
been puri¢ed from the porcine brain by a⁄nity chromatogra-
phy using an immobilized crotoxin column. Partial amino
acid sequence of the 50 kDa polypeptide has also been re-
ported [16^18]. Herein we report the complete cDNA se-
quence and the deduced amino acid sequence of the 50 kDa
polypeptide1 which is a new member of calcium-binding pro-
teins. We now propose the name crocalbin (for crotoxin and
calcium-binding protein) for this protein, which was referred
to previously as CBP-50. We pursued the study of crocalbin
with the assumption that it may be involved in part in the
actions of crotoxin. A similar approach has also been taken
for other PLA2s with or without toxicity [19^28] [29^33].
Complete sequences have been reported for a binding protein
for pancreatic PLA2 and other non-neurotoxic PLA2s, and for
two binding proteins for taipoxin, which is also a PLA2 neu-
rotoxin [28^32].
2. Materials and methods
2.1. Materials
Calcium-45 was obtained from Amersham, and PVDF membrane
ProBlott from Applied Biosystems. Marathon-ready cDNA library of
rat brain and Advantage KlenTaq polymerase Mix were purchased
from Clontech. Cloning vector pGEM-T, JM-109 cell line, and Wiz-
ard plus plasmid puri¢cation kit were from Promega. DNA primers
were synthesized by a local company.
2.2. Methods
Rapid ampli¢cation of cDNA ends (RACE) was employed to gen-
erate complete cDNA sequence encoding crocalbin. Marathon-ready
cDNAs of rat brain were used as templates in RACE polymerase
chain reaction (PCR) [34,35] to obtain the 5P-end cDNA fragment.
The PCR reactions were performed by using two primers: Marathon
adaptor primer AP1 as the sense primer, and gene-speci¢c oligonu-
cleotide encoding the internal sequence TEGELKSRIKHAQK of cro-
calbin as the antisense primer. The latter primer is a non-degenerate
42-mer oligonucleotides (5P-CTTCTGGGCGTGCTTGATCCGGC-
TCTTCAGCTCGCCCTCGGT-3P), designed on the basis of the
above amino acid sequence with the third nucleotides of degenerate
codons for amino acids to be the nucleotide appeared most frequently
in known DNA sequences encoding the proteins of rat brain. The
thermal condition in the reaction was subjected to 25 cycles of denat-
uration (94‡C, 1 min), annealing (60‡C, 1 min), and extension (72‡C,
1 min). After the cycling, the PCR reaction was allowed to proceed
further for 4 min at 72‡C. The PCR product was puri¢ed on 1.2%
agarose gel, and then ligated to pGEM-T vector for transfecting into
competent cell, JM109. The white colonies carrying the insert was
randomly picked up and then cultured for 6 h. The plasmid was
isolated by using Wizard plus reagent kit according to the manufac-
turer’s instructions, and then subjected to automatic DNA sequenc-
ing. A 383 bp (not including AP1 sequence) cDNA fragment was
obtained.
For the generation of 3P-end cDNA fragment encoding the C-ter-
minal part of crocalbin, 3P-RACE with Marathon-ready cDNAs as
templates was utilized with gene-speci¢c oligonucleotide (5P-GGAAT-
GATTGTAGATAAAATAGACACCGATAAAGATGGG-3P) corre-
sponding to bp 297^335 of the 5P cDNA fragment of crocalbin as the
sense primer and AP1 sequence as the antisense primer. The proce-
dure of PCR was performed according to the manufacturer’s protocol
using the Advantage KlenTaq Polymerase Mix. The thermal cycles in
the reaction were as follows: 1 min at 94‡C, 5 cycles of 30 s at 94‡C
and 4 min at 72‡C, 5 cycles of 30 s at 94‡C and 4 min at 70‡C, 25
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cycles of 20 s at 94‡C and 4 min at 68‡C. The PCR products were gel
puri¢ed, subcloned into pGEM-T vector and sequenced as above. It
was observed that the last 87 bp of the 5P-end fragment match totally
with the ¢rst 87 bp of the second PCR product (3P-end fragment)
which contains poly-A tail.
Detection of Ca2 binding by crocalbin was performed by the cal-
cium overlay assay (45Ca autoradiography) as described by Maruya-
ma et al. [36] with modi¢cations. Brie£y, after SDS polyacrylamide gel
electrophoresis proteins were blotted onto PVDF membrane, and then
washed three times with a solution of 60 mM KCl, 5 mM MgCl2, 10
mM imidazole-HCl, pH 6.8 to get rid of the electrode bu¡er. The
membrane was incubated in the same bu¡er containing 1 mCi/l
45Ca for 45 min at room temperature. Unbound 45Ca was removed
by rinsing with 50% methanol. After drying, autoradiography was
carried out with X-ray ¢lm for 72 h exposure at 380‡C.
3. Results
3.1. Cloning and sequencing of crocalbin from the rat brain
cDNA
Previously we reported the partial amino acid sequence
KPTEKKDRVHHEPQL for the N-terminal part of crocalbin
(CBP-50) puri¢ed from porcine brain, and IVDKI-
DADKDGFVTEGELKSRIKHAQK for part of an internal
fragment [17,18]. Based on the latter partial sequence, a 42-
mer oligonucleotide corresponding to the last 14 amino acid
residues of the sequence was used as primer (together with
AP1) to amplify Marathon-ready cDNA library of rat brain
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Fig. 1. Nucleotide sequence of crocalbin cDNA and predicted amino acid sequence of the protein. Nucleotides and amino acids are numbered
to the right with single-letter codes for the amino acids shown below the nucleotide sequence. The leader signal, the polyadenylation signal and
the poly-A tail are underlined. The sequence data are available from GenBank/EMBL/DDBJ under accession number AJ001929.
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by PCR with the assumption that this segment of the rat and
that of the porcine are highly conserved (they turned out to be
identical). After 5P-RACE followed by 3P-RACE, complete
nucleotide sequence of the rat cDNA for crocalbin was ob-
tained and the amino acid sequence deduced (Fig. 1). There
are two potential initiator methionines within a distance of
7 amino acid residues. The vicinity of the ¢rst AUG codon,
but not the second, matches perfectly with the consensus se-
quence for initiator methionine as de¢ned by Kozak [37,38],
namely a purine at position 33 and a guanine at position +4.
Furthermore, in line with the generalization of signal peptides
of 18^20 residues in length for eukaryotic proteins synthesized
on rough endoplasmic reticulum (rER) [39], translation start-
ing from the ¢rst initiator methionine will give a signal pep-
tide for crocalbin of 19 residues, as inferring from the N-
terminal amino acid sequence determined for the mature pro-
tein by direct protein sequencing versus the sequence deduced
from the cDNA. Therefore, we numbered the ¢rst methionine
as position +1 in this report. Thus the 3166 bp nucleotide
sequence contains an open reading frame of 945 bp, a 77 bp
5P-untranslated region, and a 2144 bp 3P-untranslated region.
The signal sequence is made up of mostly hydrophobic resi-
dues and conforms to the 33, 31 rule [39] of small, un-
charged residues at the 31 and 33 positions, which are Ser
and Ala, respectively, for crocalbin, relative to the signal pep-
tidase cleavage site. Thus the mature protein encoded by the
crocalbin cDNA is 296 amino acid residues in length, and the
predicted molecular mass is 34 861 Da. Judging from the de-
duced protein sequence, there is only one potential N-glyco-
sylation site, which is located at residue 112 of the mature
protein (Fig. 2). Only one amino acid residue in the partial
sequence determined previously (see above) for the porcine
protein is di¡erent from the deduced sequence of the rat pro-
tein (residue 63 of Fig. 2), indicating that crocalbin is highly
conserved and thus deserves further study.
A survey of the GenBank and the SwissProt databases re-
vealed that only the small family of reticulocalbin-type pro-
teins [40] show signi¢cant homology to crocalbin. These are
calumenin (87.8%), reticulocalbin (58.2%), DNA supercoiling
factor (53.1%), yk67a3.5 (46.2%), ERC-55 (38.5%), TCBP-49
(37.7%), and Cab45 (25.1%). Although the score of sequence
similarity between crocalbin and calumenin is high, the amino
acid residues between 71 and 113 are only 53.5% identical
(Fig. 2).
3.2. Crocalbin is a calcium-binding protein of the EF-hand type
Similar to reticulocalbin and many other calcium-binding
proteins, the crocalbin sequence also contains domains satis-
fying the general feature for high-a⁄nity calcium-binding EF-
hand domains according to Kretsinger’s rule [44]. As shown in
Fig. 3, six segments of such domains exist in the crocalbin
sequence. The ¢ve oxygen-containing residues responsible
for the coordination of Ca2 are present in all of the six
domains. Although the match of domain III with the consen-
sus sequence is less than perfect, similar deviations also occurs
in other calcium-binding proteins, e.g. reticulocalbin, calpain,
calumenin, ERC-55, and Cab45 [40^43,45]. Although the cen-
tral residue in domain III is Leu instead of the conserved Gly,
the same replacement occurs in some other Ca2-binding pro-
teins and was considered to be compatible with Ca2 binding
on the basis of secondary structure prediction [40,46,47]. The
six calcium-binding domains of crocalbin show signi¢cant se-
quence homology with segments of a large number of calci-
um-binding proteins, though only the reticulocalbin family of
proteins show homology outside the Ca2-binding domains.
To assess whether crocalbin actually binds Ca2, the calci-
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Fig. 2. Sequence alignment of crocalbin with calumenin. The predicted amino acid sequences of mature crocalbin (rat) and of calumenin
(mouse) are aligned by the Gene Stream align program. The conserved residues are highlighted.
Fig. 3. Alignment of potential calcium-binding domains in crocalbin
with EF-hand motif. a: Schematic representation of crocalbin struc-
ture. Crocalbin has a signal sequence (ss) and six EF-hand domains.
Arabic numbers indicate positions of these landmarks. Roman num-
bers refer to the EF-hands. b: The protein sequence deduced for
crocalbin was analyzed for homologies to the test sequence for EF-
hand motif. In the test sequence, P and o represent hydrophobic
and oxygen-containing residues, respectively.
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um-45 overlay (Ca2 autoradiography) assay was employed.
The puri¢ed crocalbin was subjected to SDS polyacrylamide
gel electrophoresis, transferred to PVDF membrane, and then
incubated with 45Ca. As shown by the autoradiogram of the
membrane, puri¢ed crocalbin did indeed bind Ca2. The band
corresponding to crocalbin in the synaptosome preparation
showed little if any radioactivity, re£ecting that crocalbin is
a minor protein in the cell. A protein of 20 kDa appears to be
the major calcium-binding protein in the synaptosome prepa-
ration (Fig. 4), the identity of which is currently not known.
4. Discussion
In this study, we have shown that crocalbin is a highly
conserved new protein, and established that it is a calcium-
binding protein with the EF-hand motifs. Previously we re-
ported a molecular mass of V50 kDa for crocalbin on the
basis of SDS gel mobility [16,18], which is considerably higher
than that calculated from the deduced amino acid sequence.
This behavior has also been observed for reticulocalbin, ERC-
55, and Cab45 [40,42,43]. Data are lacking as regards whether
other proteins in the reticulocalbin family share this property.
Although TCBP-49 (from rat) is only 6 40% homologous
to crocalbin, it binds to taipoxin, which is also a PLA2 neuro-
toxin related to crotoxin. TCBP-49 has been shown to be
present in vesicular and reticular structures (presumably inside
the lumina), and has been suggested to bind taipoxin after the
toxin was internalized into the endomembrane systems by
endocytosis following binding of the toxin to membrane ac-
ceptors [32]. Crocalbin may behave in similar fashion after
crotoxin is internalized. In support of this hypothesis, most
of the proteins homologous to crocalbin were shown to be
distributed in the endomembrane systems and suggested to
play some role in protein synthesis, modi¢cation, intracellular
transport or Ca2-dependent regulation of other proteins [40^
43], and no data are available for the rest. Members of the
reticulocalbin family of calcium-binding proteins contain a
HDEL, HDEF or HEEF tetrapeptide sequence at the C-ter-
mini, which appears to be (at least partly) the ER or Golgi
retention motif. The C-terminal sequence of HDEF for cro-
calbin also ¢ts in this picture.
Although the homology between crocalbin (from rat) and
calumenin (from mouse or human) is high, crocalbin appears
not to be the rat counterpart of calumenin, as evidenced by
the following observations. Both calumenin and crocalbin are
very highly conserved proteins, since calumenin from mouse
and that from human [41,48] are almost identical (97.6% se-
quence identity), and our data showed that the sequence iden-
tity between human (unpublished data) and rat crocalbin is
also very high (95.3%). Furthermore, although the sequences
near both N- and C-termini of crocalbin and calumenin are
almost identical, the amino acid residues between 71 and 113
are only 53.5% identical (Fig. 2). Thus this study substantiates
our previous claim [18] that crocalbin (CBP-50) is a new mem-
ber of the yet small family of reticulocalbin-like calcium-bind-
ing proteins. It remains to be resolved whether crocalbin and
calumenin represent isoforms of similar function or are dis-
tinct proteins serving di¡erent physiological roles. The calum-
enin sequence, determined by the signal sequence trap method
[41], was reported after the partial sequence of crocalbin was
published [16,17]. Puri¢cation of most members of the retic-
ulocalbin family has not been reported, whereas crocalbin and
TCBP-49 have been highly puri¢ed using immobilized crotox-
in and taipoxin columns, respectively, useful for further bio-
chemical and other studies.
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